Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta, sending shares down 2.5% after the bell.

The New York Times will take down Vertex on Aug. 29. By Everdeen Mason My favorite part of this job is creating new things. I love the feeling of laboring with a group of kindred spirits to make ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

On Monday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported lower-than-expected first-quarter 2025 earnings. Vertex reported first-quarter adjusted earnings per share of $4.06, down from ...

The Greenworks 80V 500 CFM Leaf Blower is on sale for just $135, a 46% discount on its normal price of $250. This model is a top-20 bestseller on Amazon with a long-lasting battery that helps it ...

Amazon is once again offering major savings on the Greenworks PRO CrossoverZ 80V 42-inch Electric Zero-Turn Lawn Mower now at $4,999 shipped. Normally fetching $6,000, it has spent most of 2024 ...

Vertex Pharmaceuticals Inc VRTX is entering earnings week with some serious anticipation — and a bit of heartburn. The stock had a solid run in 2025, up nearly 20% year-to-date and 21% over the ...

IDG. Figure 4. A sample pipeline built with Vertex AI Vision. Deploying a Vertex AI Vision pipeline. Once the pipeline is built visually, it can be deployed to start performing inference.

Vertex Pharmaceuticals' (VRTX 1.64%) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date.

In this webinar, Bruker Optics explains how their VERTEX research FT-IT spectrometers can reach the THx spectral range below 50cm-1. ... The verTera Terahertz extension for the VERTEX 80v vacuum ...

Fye highlighted that Vertex’s 2025 revenue guide of $11.75 billion to $12 billion is primarily powered by cystic fibrosis therapies, but she also noted "two potential upside levers" to that figure: ...